Home › Bile Duct Cancer (Cholangiocarcinoma) › Texas › Houston
Pag-aaral pangklinika para sa Bile Duct Cancer (Cholangiocarcinoma) sa Houston, TX
Isang pag-aaral para sa Bile Duct Cancer (Cholangiocarcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of PHST001 in Advanced Solid Tumors
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- University of Texas MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
- Baylor College of Medicine, Houston
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Nagre-recruitPhase 1/2
- Next Oncology - Houston, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- University of Texas MD Anderson Cancer Center, Houston
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Nagre-recruitPhase 1/2
- University of Texas, MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Nagre-recruitPhase 1/2
- MD Anderson Cancer Center, Houston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
Nagre-recruitObservasyonal na pag-aaral
- M D Anderson Cancer Center, Houston
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Nagre-recruitPhase 2
- M D Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Houston
Pag-aaral para sa Bile Duct Cancer (Cholangiocarcinoma) sa ibang lungsod
- New York City, NY11 pag-aaral
- Boston, MA8 pag-aaral
- Rochester, MN7 pag-aaral
- Arlington, VA7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Chicago, IL7 pag-aaral
- Columbus, OH6 pag-aaral
- Cleveland, OH6 pag-aaral
- Edison, NJ5 pag-aaral
- Queens, NY5 pag-aaral
- Grand Rapids, MI5 pag-aaral
- Nashville, TN5 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)121 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer102 pag-aaral
- Kanser sa Ovary89 pag-aaral
- Acute Myeloid Leukemia85 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium68 pag-aaral
- Kanser sa Pancreas61 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.